An organ-on-a-chip (OOC) is the multi-channel 3-D microfluidic cell culture, integrated circuit (chip) that simulates the activities, mechanics and the physiological rejoinder of a whole organ or an organ system, a type of artificial organ. This chip progresses a narrow channel for the blood and air flow in organs such as lung, gut, liver, heart, and several others. Such devices introduce multiple levels of tissue and organ functionalities, which are not feasible utilizing the conventional 2D and 3D culture systems. Organ-on-chip offers an extensive variety of applications such as diseases modelling, patient delamination, and phenotypic screening.
According to the report analysis, ‘Global Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Region: Trend Forecast and Growth Opportunity’ states that the global organ-on-chip market is predicted to augment owing to the increasing use of organ-on-a-chip (OOC) is early detection of drug toxicity, growing requirement for the customized medicine, the emergence of OOC as a substitute to animal testing, the proficient increment in research funding and venture capital investments.
AxoSim Inc., BiomimX SRL, Cherry Biotech, CN Bio Innovations, Ltd., Emulate Inc., Hurel Corporation, InSphero AG, Kirkstall, Ltd., MIMETAS BV, Nortis Inc., Organovo, Inc., SynVivo, Inc., Tara Biosystems Inc., TissUse GmbH and many more are the foremost entities which presently working in the global organ-on-chip market more proficiently for ruling around the globe, leading the highest market growth, keep maintaining the governing position, generating the high percentage of revenue, and registering the great value of market share by establishing the countless research and development programs, improving the qualitative and quantitative measures of such, spreading the awareness connected to the applications and advantages of organ-on-a-chip, implementing the policies of profit making and strategies of expansion, delivering the better consumer satisfaction, increasing the features and benefits of organ-on-a-chip and employing the young and active personnel.
On the basis of offering, the global organ-on-a-chip market is categorized into chips and service. On the basis of organ type, the global organ-on-a-chip market is classified into liver-on-a-chip, heart-on-a-chip, Lung-on-a-Chip, Kidney-on-a-Chip, Brain-on-a-Chip, Skin-on-a-Chip, Vessels-on-a-Chip, and several other Organ Types. Whereas, the heart-on-chip type has greater potential for growth in the worldwide market. Lung-on-chip registered the global organ-on-chip market share during the recent past years, and is projected to continue its dominance throughout the forecast period. On the basis of end user, the global organ-on-a-chip market is categorized into Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Cosmetics Industry and several other End Users.
Region wise, the global organ-on-a-chip market is scattered into different regions such as North America, Europe, APAC, South America and MEA. Whereas, it is predicted that the North America controlled the greatest market share, owing to the improvements in the innovative technologies and increment in the healthcare applications. In addition, the Asia Pacific region is predicted to observe the greatest growth rate throughout review duration, owing to lucrative choices suggested by regions likewise India, China and Japan.
For More Information, click on the link below:-
Global Organ-on-Chip Market Research Report
Related Report:-
Follow Us:
LinkedIn | Instagram | Facebook | Twitter | YouTube
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
